Nykredit A/S’s BioNTech BNTX Stock Holding History

Nykredit A/S’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$293K	Buy	+3,149	New	+$296K	﹤0.01%	878

Other funds holding BNTX

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

GSK plc London $602M AUM

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

DCP

Davern Capital Partners Ny, New York $587M AUM

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Nykredit A/S's BNTX Position: Q2 2026 in Review

Nykredit A/S opened a new position in BioNTech (BNTX) in Q2 2026: 3,149 shares worth $293K. The stake represents ﹤0.01% of the portfolio and ranks #878 among its holdings.

202 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

Nykredit A/S held 3,149 shares of BioNTech worth $293K as of Q2 2026.
BioNTech was a new Nykredit A/S position in Q2 2026.
BioNTech made up ﹤0.01% of Nykredit A/S's portfolio in Q2 2026, its #878 holding.
202 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Nykredit A/S's 13F filing for Q2 2026, filed 13 Aug 2026.